Related Experiment Video
Updated: Nov 26, 2025
05:56
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
1.6K
Management of postdischarge nausea and vomiting
Mikhail Dziadzko1, Frédéric Aubrun1
1Service Anesthésie Réanimation Douleur, Université Lyon 1, Hospices Civils de Lyon, Hôpital de la Croix-Rousse, 103 Grande Rue de la Croix-Rousse, 69317 LYON Cédex 04, France.
Best Practice & Research. Clinical Anaesthesiology
|December 8, 2020
Summary
Postdischarge nausea and vomiting (PDNV) affects many patients after surgery, often due to pain medication. Proactive risk assessment and tailored antiemetic strategies are key for managing PDNV effectively.
Area of Science:
- Anesthesiology
- Surgical Patient Care
Background:
- Postdischarge nausea and vomiting (PDNV) affects over 30% of patients post-ambulatory surgery.
- PDNV is frequently linked to analgesic use for postsurgical pain management.
- Existing prediction scores and guidelines for PONV/PDNV management are available.
Purpose of the Study:
- To highlight the significance of PDNV in ambulatory surgery.
- To emphasize the need for risk assessment and tailored interventions for high-risk patients.
- To underscore the importance of patient education and institutional protocols in PDNV management.
Main Methods:
- Utilizing validated PDNV prediction scores for risk assessment.
- Implementing evidence-based consensus guidelines for PONV/PDNV management.
- Employing adapted pharmacological interventions, including combination antiemetics and home access.
Main Results:
- High-risk patients demonstrate improved outcomes with predischarge assessment and intervention.
- Combination therapy with long- and short-acting antiemetics is beneficial.
- Patient education and clinician involvement in protocols are crucial.
Conclusions:
- A systematic approach involving risk assessment, pharmacological intervention, and patient education is vital for PDNV management.
- Multidisciplinary collaboration in developing and implementing institutional protocols is essential.
- Continuous quality control and patient feedback enhance the efficiency of PDNV management strategies.
Related Concept Videos
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
387
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
387
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
657
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
657
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
465
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
465
01:31Discharge Summary Forms
1.1K
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.1K
01:22Aneurysm IV: Nursing Management
224
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
224
01:28Esophageal Varices-II: Clinical Features and Management
247
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
247